Immune to Cancer: The CRI Blog
-
AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells
At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…
-
Novel CAR Immunotherapies for Pancreatic Cancer with Dr. Ryan Alexander
CRI Fellow Ryan Alexander is developing new cellular immunotherapies for pancreatic cancer.
-
Improving Cell Therapies by Characterizing Our Immune Arsenal with CRI STAR Dr. Ning Jenny Jiang
Dr. Ning Jenny Jiang, a CRI Lloyd J. Old STAR at the University of Pennsylvania, is working to…
-
Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee
CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with…
-
ASCO21 Recap: Immunotherapy’s Continued Progress and Addressing Healthcare Disparities
ASCO21 highlighted the latest immunotherapy advances in checkpoint inhibition and cell therapies, and addressed disparities in healthcare.
-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
AACR21 Recap: CRI Scientists Highlight the Latest in ‘Discovery Science Driving Clinical Breakthroughs’
During AACR21, CRI scientists highlighted how improving our understanding of basic immune biology may enable improved immunotherapies…
-
CRI Speaks with Dr. Steven A. Rosenberg, Winner of the 2020 AACR-CRI Lloyd J. Old Award in Cancer Immunology
Dr. Steven A. Rosenberg receives the 2020 AACR-CRI Lloyd J. Old Award in Cancer Immunology on June…
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.